In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 7, 2010, Pages 3015-3017

  Zapor, Michael J ^a   Barber, Melissa ^b   Summers, Amy ^a   Miller, George H ^c   Feeney, Lee Ann ^c   Eberly, Lynn E ^d   Wortmann, Glenn ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Infectious Diseases Clinical Research Program   (United States)

^c Achaogen Inc   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GATIFLOXACIN; GEMCITABINE; HABEKACIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; MOXIFLOXACIN; PIPERACILLIN; POLYMYXIN; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; DIBEKACIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BATTLE INJURY; DRUG POTENTIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SOLDIER; ANALOGS AND DERIVATIVES; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PUBLIC HOSPITAL; WAR;

ACINETOBACTER BAUMANNII; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DIBEKACIN; HOSPITALS, MILITARY; HUMANS; MICROBIAL SENSITIVITY TESTS; WAR;

EID: 77953797218     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01173-09     Document Type: Article

References (21)

1. Ambrose, P. G., S. M. Bhavnani, C. M. Rubino, A. Louie, T. Gumbo, A. Forrest, and G. L. Drusano. 2007. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore. Clin. Infect. Dis. 44:79-86.
2. Chung, M., R. Costello, S. Symchowicz. 1980. Comparison of netilmicin and gentamicin pharmacokinetics in humans. Antimicrob. Agents Chemother. 17:182-187.
3. CLSI. 2009. Performance standards for antimicrobial susceptibility testing: 18th informational supplement. CLSI document M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Cordeiro, J. C., A. O. Reis, E. A. Miranda, H. S. Sader, and the Arbekacin Study Group. 2001. In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals. Braz. J. Infect. Dis. 5:130-135.
5. European Committee on Antimicrobial Susceptibility Testing. 2009. Consensus document: aminoglycosides - EUCAST clinical MIC breakpoints (version 1.5). http://www.srga.org/eucastwt/MICTAB/MICaminoglycosides.html.
6. Giamarellos-Bourboulis, E. J., P. Grecka, and H. Giamarellou. 1996. Invitro interactions of DX-8739, a new carbapenem, meropenem, and imipenem with amikacin against multiresistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 38:287-291.
7. Hartzell, J. D., R. Neff, J. Ake, R. Howard, S. Olson, K. Paolino, M. Vishnepolsky, A. Weintrob, and G. Wortmann. 2009. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin. Infect. Dis. 48:1724-1728.
8. Isenberg, H. D. 1992. Synergy testing by disk agar diffusion methods, section 5.18. In Clinical microbiology procedures handbook, vol. 1. ASM Press, Washington, DC.
9. Isenberg, H. D. 1992. Synergy testing: broth microdilution checkerboard and broth macrodilution methods, section 5.18. In Clinical microbiology procedures handbook, vol. 1. ASM Press, Washington, DC.
10. Kak, V., S. M. Donabedian, M. J. Zervos, R. Kariyama, H. Kumon, and J. W. Chow. 2000. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance. Antimicrob. Agents Chemother. 44:2545-2546.
11. Kobayashi, Y., H. Uchida, and Y. Kawakami. 1992. Synergy with aztreonam and arbekacin or tobramycin against Pseudomonas aeruginosa isolated from blood. J. Antimicrob. Chemother. 30:871-872.
12. Lee, J. Y., W. S. Oh, K. S. Ko, S. T. Heo, C. S. Moon, H. K. Ki, S. Kiem, K. R. Peck, and J. H. Song. 2006. Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus. J. Korean Med. Sci. 21:188-192.
13. Miller, G. H., F. J. Sabatelli, R. S. Hare, Y. Glupczymski, P. Mackey, D. Shlaes, K. Shimizu, K. J. Shaw, and the Aminoglycoside Resistance Study Groups. 1997. The most frequent aminoglycoside resistance mechanisms - changes with time and geographic area: a reflection of aminoglycoside usage patterns? Clin. Infect. Dis. 24:S46-S62.
14. Mingeot-Leclercq, M.-P., Y. Glupczynski, and P. M. Tulkens. 1999. Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43:727-737.
15. Owens, B. D., J. F. Kragh, Jr., J. C. Wenke, J. Macaitis, C. E. Wade, and J. B. Holcombe. 2008. Combat wounds in Operation Iraqi Freedom and Operation Enduring Freedom. J. Trauma 64:295-299.
16. Sato, R., Y. Tanigawara, M. Kaku, N. Aikawa, and K. Shimizu. 2006. Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 50:3763-3769. (Pubitemid 44684891)
17. Schwartz, D. C., W. Saffran, J. Welsh, R. Haas, M. Goldenberg, and C. R. Cantor. 1983. New technique for purifying large DNAs and studying their properties and packaging. Cold Spring Harb. Symp. Quant. Biol. 47:189-195.
18. Tozuka, Z. 1993. Aminoglycosides - parameters, p. 107-108. In H.-P. Kuemmerle, T. Murakawa, and C. H. Nightingale (ed.), Pharmacokinetics of antimicrobial agents: principles, methods, and applications. Ecomed, Landsberg, Germany.
19. Umezawa, H., and S. Kondo. 1982. Mechanisms of resistance to aminoglycoside antibiotics, p. 282. In Handbook of experimental pharmacology, vol. 62. Aminoglycoside antibiotics. Springer-Verlag, New York, NY.
20. Yasuhiro, S., O. Tikashi, and I. Koichi. 2001. Evaluation of arbekacin and antibacterial agents synergy for MRSA isolated from blood cultures. Jpn. J. Chemother. 49:89-94.
21. Zapor, M. J., D. Erwin, G. Erowele, and G. Wortmann. 2008. Emergence of multidrug resistance in bacteria and impact on antibiotic expenditure at a major Army medical center caring for soldiers wounded in Iraq and Afghanistan. Infect. Control Hosp. Epidemiol. 29:661-663.